Malaysian Biotechnology Sector

< BACK TO INFORMATION TECHNOLOGY starstarstarstarstar   Science - Information Technology Press Release
2nd April 2009, 11:06pm - Views: 918

Science Information Technology Frost & Sullivan 1 image

Science Information Technology Frost & Sullivan 2 image

Malaysian Biotechnology Sector

KUALA LUMPUR, Apr. 2 /PRNewswire-AsiaNet/ --

                    The Impact of the Global Economic Crisis

    The global credit crisis and subsequent decline in worldwide economic

activity has spawned a growing crisis that has engulfed the Asia Pacific

region. Countries within the APAC community are heavily dependent on export

earnings from major markets in the US and EU - collapsing demand in these

countries is decreasing revenue flows into the region.


    Frost and Sullivan, Senior Vice President of Healthcare Asia Pacific

Reenita Das anticipates, "The economy will continue to decline in the first

half of 2009 and will stage a modest recovery in the first half of 2010. The

biotechnology sector is a diverse sector, and the economic crisis has had a

disproportionate impact on different parts of this sector."

    Das further elaborates, "The biotech industry is expected to continue to

grow by about 10 to 15 percent globally reaching USD271 billion by 2011. The

healthcare segment is the largest contributor to the overall Biotechnology

sectors revenues (62.6 percent in 2007). Bio-agriculture is the second

largest segment, accounting for 11.5 percent of total revenues. Others

include areas such as bio-fuels and industrial biotechnology."

    Having said the above, activities in the bio-fuels sectors have declined

substantially while the healthcare biotechnology sector has declined by a

modest amount relative to the global economy.

    As a result, 2009 will continue to pose challenges to the region life

sciences company that are in the development stage due to the limited capital

availability. The global pharmaceutical industry is facing an unprecedented

opportunity. Over the next decade by 2020, the pharmaceutical market will

double in size reaching USD1.3 trillion to meet the medical needs of the

aging global population and a surge in demand from emerging countries.

    "It is said that the overall revenue in the biotechnology is expected to

grow continuously on a yearly basis. In 2005-2006 there was a 12.6 percent

increase in global biotechnology revenues," said Das.

    Biotechnology is a diverse sector and contain key areas that are less

exposed to shifts in consumer demand. The current crisis will slow the growth

of the global biotechnology sector but this will not change its long term

optimistic outlook. A renewed focus on the sector is critical as several key

Malaysian exports are highly dependent on continued consumer spending by

western consumers.

    About Frost & Sullivan

    Frost & Sullivan, the Growth Partnership Company, enables clients to

accelerate growth and achieve best in class positions in growth, innovation

and leadership. The company's Growth Partnership Service provides the CEO and

the CEO's Growth Team with disciplined research and best practice models to

drive the generation, evaluation and implementation of powerful growth

strategies. Frost & Sullivan leverages over 45 years of experience in

partnering with Global 1000 companies, emerging businesses and the investment

Science Information Technology Frost & Sullivan 3 image

community from 31 offices on six continents. To join our Growth Partnership,

please visit


    Emmie Kaur

    Corporate Communications -Healthcare, Asia Pacific

    DID: +603 6204 5913


    Jasminder Kaur

    Corporate Communications -Healthcare, Asia Pacific

    DID: +65 6890 0937


    SOURCE Frost & Sullivan

    CONTACT: Emmie Kaur, DID: +603 6204 5913,, or

Jasminder Kaur, DID: +65 6890 0937,, both of Frost & Sullivan

Corporate Communications -Healthcare, Asia Pacific


To view this and other AsiaNet releases please visit

news articles logo NEWS ARTICLES
Contact News Articles |Remove this article